These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19773201)

  • 1. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
    Rao V; Saunes M; Jørstad S; Moen T
    Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
    Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
    Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
    Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
    Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J; Taylor P
    J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.
    Gasová Z; Spísek R; Dolezalová L; Marinov I; Vítek A
    Transfus Apher Sci; 2007 Apr; 36(2):149-58. PubMed ID: 17376742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
    Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J; Taylor PC
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E; Vonderheid EC; Geskin L
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photochemotherapy--present and future.
    Knobler R
    Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
    Fondi C; Nozzoli C; Benemei S; Baroni G; Saccardi R; Guidi S; Nicoletti P; Bartolozzi B; Pimpinelli N; Santucci M; Bosi A; Massi D
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):938-47. PubMed ID: 19589483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells.
    Di Biaso I; Di Maio L; Bugarin C; Gaipa G; Dander E; Balduzzi A; Parma M; D'Amico G; Perseghin P; Biondi A; Biagi E
    Transplantation; 2009 May; 87(9):1422-5. PubMed ID: 19424046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.